• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Budget impact analysis of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.

作者信息

Kondo Masahide, Hoshi Shu-Ling, Toi Masakazu

机构信息

Department of Health Care Policy and Management, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305-8577, Japan.

出版信息

Jpn J Clin Oncol. 2009 Nov;39(11):767-70. doi: 10.1093/jjco/hyp081. Epub 2009 Aug 5.

DOI:10.1093/jjco/hyp081
PMID:19656807
Abstract

'Cost saving' was suggested in our recent economic evaluation of chemoprevention of breast cancer targeting women at high risk in Japan. However, this budget impact analysis reveals that the introduction of chemoprevention appears to be not budget saving for approximately 20 years, whereas the level of budget impact seems affordable.

摘要

相似文献

1
Budget impact analysis of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.
Jpn J Clin Oncol. 2009 Nov;39(11):767-70. doi: 10.1093/jjco/hyp081. Epub 2009 Aug 5.
2
Chemoprevention of breast cancer.乳腺癌的化学预防
South Med J. 2001 Jan;94(1):7-15.
3
Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.特别工作组对化学预防持谨慎态度。关于服用他莫昔芬和雷洛昔芬预防乳腺癌的官方指南已经出台。这些药物会有帮助，但并非适用于所有人。
Harv Womens Health Watch. 2002 Oct;10(2):1-2.
4
[Breakthrough in breast cancer chemoprevention].[乳腺癌化学预防的突破]
Orv Hetil. 2003 Mar 30;144(13):597-603.
5
Tamoxifen and raloxifene may benefit women at high risk for breast cancer.他莫昔芬和雷洛昔芬可能对乳腺癌高危女性有益。
Rep Med Guidel Outcomes Res. 2002 Jul 26;13(14):1-2, 5.
6
Chemoprevention: drug pricing and mortality: the case of tamoxifen.化学预防：药物定价与死亡率——以他莫昔芬为例
Cancer. 2006 Sep 1;107(5):950-8. doi: 10.1002/cncr.22075.
7
Targeted antiestrogens for the prevention of breast cancer.
Oncol Res. 1999;11(9):401-7.
8
The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.STAR试验：雷洛昔芬作为绝经后女性降低乳腺癌风险药物的证据。
J Natl Compr Canc Netw. 2007 Sep;5(8):719-24.
9
[Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].乳腺癌的化学预防。药物预防的临床试验
Medicina (B Aires). 2004;64(1):66-72.
10
Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.在乳腺癌风险增加的绝经后女性中，选择性雌激素受体调节剂治疗的风险、益处及对生活质量的影响。
Menopause. 2008 Jul-Aug;15(4 Suppl):797-803. doi: 10.1097/gme.0b013e31817be9af.

引用本文的文献

1
"Budget impact analyses": a practical policy making tool for drug reimbursement decisions.“预算影响分析”：药物报销决策的实用政策制定工具。
Iran J Pharm Res. 2014 Summer;13(3):1105-9.